Retrospective study of postoperative transfusion management for cardiac surgery: comparison between HES130/0.4 and 5% albumin
2017 Volume 21 Issue 1 Pages 145-150
Details
2017 Volume 21 Issue 1 Pages 145-150
Background: The optimal transfusion strategy in the perioperative management for cardiac surgery has not been established yet. We investigated whether HES 130/0.4 can be safely used as an alternative to 5% albumin.
Methods and results: Among non-dialysis patients scheduled to undergo cardiac surgery who were admitted to the intensive care unit (ICU) between April 1, 2014, and March 31, 2015, 88 who required non-infusion load, HES 130/0.4, and 5% albumin were included in this retrospective study. In terms of water balance on the day of surgery, the presence of acute kidney injury, lengths of ICU and hospital stay, no significant differences were found among the three groups.
Conclusion: In the perioperative management of cardiac surgery, HES 130/0.4 can be used as an alternative to 5% albumin.
